이용현 교수는 현재 이화여자 대학교 약학대학에서 약제학(약물송달학)분야의 교수로 재직중에 있다. 부산대학교 약학대학에서 학/박사를 취득한 후, 한국과학기술원과 University of Michigan에서 Postdoctoral Researcher/Research Scientist로서 활발히 연구를 수행하였다. 의약화학, 나노약학, 면역공학등 다양한 분야에서 암 및 난치성염증질환의 효과적인 치료 및 조절을 목표로 장내미생물조절, 면역체계 조절 등 다양한 방식을 활용한 새로운 약물치료전략을 개발하여, 이 분야에서 세계적으로 권위 있는 국제학술지인 Nature Materials, Angewandte Chemie, Advanced Science, Biomaterials 등에 논문을 40 여편 발표하고 다양한 특허출원/등록/기술이전 등의 실적을 가지고 있다. 한국과학기술한림원에서 선정한 최우수 젊은 과학자상을 비롯한 다양한 분야에서 수상을 하였으며, 약물전달분야에서 세계적인 학회인 Controlled Release Society (CRS) Annual Meeting, Biomedical Engineering Society (BMES) Annual Meeting에서 강연을 하였고, 노벨상주간에 스웨덴 스톡홀름에서 열린 1st KAST(한림원)-KSSEA 젊은과학자/엔지니어 오픈포럼에 한국의 젊은 과학자 10인으로 참석하여 강연및 토론하는등, 활발한 연구활동을 펼치고 있다.
Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapyJournal of Nanobiotechnology, 2024, v.22 no.1, 109
Hyaluronic Acid-Bilirubin Nanoparticles as a Tumor Microenvironment Reactive Oxygen Species-Responsive Nanomedicine for Targeted Cancer TherapyINTERNATIONAL JOURNAL OF NANOMEDICINE, 2024, v.19, 4893-4906
PEGylated bilirubin-coated iron oxide nanoparticles as a biosensor for magnetic relaxation switching-based ros detection in whole bloodTheranostics, 2020, v.10 no.5, 1997-2007
Preparation and Evaluation of Amino Acid Conjugates of Celecoxib as Prodrugs to Improve the Pharmacokinetic and Therapeutic Properties of CelecoxibPHARMACEUTICS, 2020, v.12 no.11, 1043
A Hybrid Platform Based on a Bispecific Peptide-Antibody Complex for Targeted Cancer TherapyANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2019, v.58 no.7, 2005-2010
[학술지논문] Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy
Journal of Nanobiotechnology, 2024, v.22
no.1
, 1-19
SCIE
[학술지논문] Hyaluronic Acid-Bilirubin Nanoparticles as a Tumor Microenvironment Reactive Oxygen Species-Responsive Nanomedicine for Targeted Cancer Therapy
International journal of nanomedicine, 2024, v.19
no.1
, 4893-4906
[학술지논문] Smart pH-responsive nanomedicines for disease therapy
Journal of Pharmaceutical Investigation, 2022, v.52
no.4
, 427-441
SCIE
[학술지논문] Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome
ADVANCED DRUG DELIVERY REVIEWS, 2021, v.179
no.0
, 114021-114021
SCI
[학술지논문] Recent progress in development and applications of second near-infrared (NIR-II) nanoprobes
ARCHIVES OF PHARMACAL RESEARCH, 2021, v.44
no.2
, 165-181
SCIE
[학술지논문] Efficient Lymph Node-Targeted Delivery of Personalized Cancer Vaccines with Reactive Oxygen Species-Inducing Reduced Graphene Oxide Nanosheets
ACS NANO, 2020, v.14
no.10
, 13268-13278
SCI
[학술지논문] Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis
NATURE MATERIALS, 2020, v.19
no.1
, 118-118
SCI
[학술지논문] PEGylated Bilirubin-coated Iron Oxide Nanoparticles as a Biosensor for Magnetic Relaxation Switching-based ROS Detection in Whole Blood
THERANOSTICS, 2020, v.10
no.5
, 1997-2007
SCIE
[학술지논문] Preparation and Evaluation of Amino Acid Conjugates of Celecoxib as Prodrugs to Improve the Pharmacokinetic and Therapeutic Properties of Celecoxib
PHARMACEUTICS, 2020, v.12
no.11
, 1043-1043
SCIE
[학술지논문] A Hybrid Platform Based on a Bispecific Peptide-Antibody Complex for Targeted Cancer Therapy
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2019, v.58
no.7
, 2005-2010
SCI
[학술지논문] Antibody-Assisted Delivery of a Peptide-Drug Conjugate for Targeted Cancer Therapy
MOLECULAR PHARMACEUTICS, 2019, v.16
no.1
, 165-172